Over-expression of extremozyme genes in pseudomonads and closely related bacteria

Details for Australian Patent Application No. 2003215197 (hide)

Owner Dow Global Technologies Inc.

Inventors Talbot, Henry W; Chew, Lawrence C; Lee, Stacey L

Agent Spruson & Ferguson

Pub. Number AU-B-2003215197

PCT Number PCT/US03/04288

PCT Pub. Number WO2003/068926

Priority US02/04294 13.02.02 US

Filing date 13 February 2003

Wipo publication date 4 September 2003

Acceptance publication date 26 June 2008

International Classifications

C12N 15/78 (2006.01) Mutation or genetic engineering

C12N 9/10 (2006.01) Enzymes, e.g. ligases (6.) - Transferases (2.)

C12N 9/14 (2006.01) Enzymes, e.g. ligases (6.) - Hydrolases (3.)

C12N 9/28 (2006.01) Enzymes, e.g. ligases (6.)

C12N 9/42 (2006.01) Enzymes, e.g. ligases (6.) - acting on beta-1, 4-glucosidic bonds, e.g. cellulase

C12P 21/00 (2006.01) Preparation of peptides or proteins

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): US02/04294 13.02.02 US

2 October 2003 Application Open to Public Inspection

  Published as AU-B-2003215197

26 June 2008 Application Accepted

  Published as AU-B-2003215197

23 October 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003215198-Polymers derived from isobutylene and fluoro monomer

2003215196-ANCHORING ASSEMBLY FOR A MEDICAL INSTRUMENT